Lisa Lancaster
Impact in
- Pulmonary and Respiratory Medicine top 0.05%
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Medical Imaging and Pathology Studies
- Pulmonary Hypertension Research and Treatments
- Chronic Obstructive Pulmonary Disease (COPD) Research
- Respiratory and Cough-Related Research
- Occupational and environmental lung diseases
- Physiology top 0.5%
- Sarcoidosis and Beryllium Toxicity Research
Papers in
-
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis 85
- Chronic Obstructive Pulmonary Disease (COPD) Research 9
- Medical Imaging and Pathology Studies 8
- Pulmonary Hypertension Research and Treatments 7
- Respiratory and Cough-Related Research 6
- Physiology 14
- Sarcoidosis and Beryllium Toxicity Research 12
- Co-authors
- Talmadge E. King (16 shared papers)Paul W. Noble (22 shared papers)Williamson Z. Bradford (15 shared papers)Steven A. Sahn (7 shared papers)Marilyn K. Glassberg (23 shared papers)Ulrich Costabel (27 shared papers)Carlo Albera (27 shared papers)Roland M. du Bois (10 shared papers)
- Journals
- American Journal of Respiratory and Critical Care Medicine (14 papers)CHEST Journal (13 papers)BMJ Open Respiratory Research (8 papers)European Respiratory Journal (6 papers)Annals of the American Thoracic Society (4 papers)
- Partner nations
- United StatesGermanyFrance
In The Last Decade
Lisa Lancaster
97 papers receiving 10.6k citations
Lisa Lancaster's Hit Papers
Peers
Comparison fields: 5 of 127
- Pulmonary and Respiratory Medicine 8.7k
- Physiology 2.1k
- Rheumatology 661
- Pathology and Forensic Medicine 546
- Epidemiology 735
Countries citing papers authored by Lisa Lancaster
This map shows the geographic impact of Lisa Lancaster's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lisa Lancaster with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lisa Lancaster more than expected).
Fields of papers citing papers by Lisa Lancaster
This network shows the impact of papers produced by Lisa Lancaster. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lisa Lancaster. The network helps show where Lisa Lancaster may publish in the future.
Co-authors
The 25 scholars most cited alongside Lisa Lancaster, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 103 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | A Phase 3 Trial of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis Hit paper breakdown → | 2014 | 2739 |
| 2 | Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials Hit paper breakdown → | 2011 | 1558 |
| 3 | Short telomeres are a risk factor for idiopathic pulmonary fibrosis Hit paper breakdown → | 2008 | 601 |
| 4 | Effect of interferon gamma-1b on survival in patients with idiopathic pulmonary fibrosis (INSPIRE): a multicentre, randomised, placebo-controlled trial Hit paper breakdown → | 2009 | 401 |
| 5 | 2007 | 396 | |
| 6 | Forced Vital Capacity in Patients with Idiopathic Pulmonary Fibrosis: Test Properties and Minimal Clinically Important Difference Hit paper breakdown → | 2011 | 368 |
| 7 | 2010 | 346 | |
| 8 | Pirfenidone for idiopathic pulmonary fibrosis: analysis of pooled data from three multinational phase 3 trials Hit paper breakdown → | 2015 | 338 |
| 9 | 2011 | 317 | |
| 10 | 1998 | 260 | |
| 11 | 2016 | 254 | |
| 12 | 2009 | 238 | |
| 13 | 2017 | 214 | |
| 14 | 2011 | 203 | |
| 15 | 2016 | 200 | |
| 16 | 2016 | 148 | |
| 17 | 2016 | 135 | |
| 18 | 2019 | 133 | |
| 19 | 2000 | 121 | |
| 20 | 2022 | 120 |
About Lisa Lancaster
Lisa Lancaster is a scholar working on Pulmonary and Respiratory Medicine, Physiology, Immunology, Cardiology and Cardiovascular Medicine and Cancer Research, having authored 103 papers that have together received 10.9k indexed citations. Recurring topics across this work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (85 papers), Sarcoidosis and Beryllium Toxicity Research (12 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (9 papers), Medical Imaging and Pathology Studies (8 papers), Pulmonary Hypertension Research and Treatments (7 papers), Respiratory and Cough-Related Research (6 papers), NF-κB Signaling Pathways (5 papers) and Immune Response and Inflammation (5 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (8.7k citations), Physiology (2.1k citations), Rheumatology (661 citations), Pathology and Forensic Medicine (546 citations) and Epidemiology (735 citations). Lisa Lancaster has collaborated with scholars based in United States, Germany and France. Frequent co-authors include Talmadge E. King, Paul W. Noble, Williamson Z. Bradford, Steven A. Sahn, Marilyn K. Glassberg, Ulrich Costabel, Carlo Albera, Roland M. du Bois, David Kardatzke and Dominique Valeyre. Their work appears in journals such as American Journal of Respiratory and Critical Care Medicine, CHEST Journal, BMJ Open Respiratory Research, European Respiratory Journal and Annals of the American Thoracic Society.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.